Hui He Selected Research

2-methylthioadenosine

1/2021

The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui He Research Topics

Disease

49	Neoplasms (Cancer) 04/2022 - 07/2007
15	Inflammation (Inflammations) 01/2022 - 01/2011
12	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 09/2012
9	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2011
7	Prostatic Neoplasms (Prostate Cancer) 07/2016 - 11/2009
7	Dry Eye Syndromes (Dry Eye Syndrome) 01/2016 - 01/2011
6	Necrosis 11/2022 - 02/2007
6	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2008
6	Schizophrenia (Dementia Praecox) 01/2022 - 01/2017
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2021 - 08/2014
6	Urinary Bladder Neoplasms (Bladder Cancer) 08/2017 - 07/2005
5	Osteoporosis 01/2023 - 12/2019
5	Wounds and Injuries (Trauma) 01/2022 - 01/2017
5	Infections 01/2022 - 02/2009
5	Atherosclerosis 01/2022 - 12/2019
4	Carcinoma (Carcinomatosis) 01/2022 - 01/2013
4	Body Weight (Weight, Body) 01/2021 - 10/2013
4	Insulin Resistance 01/2021 - 09/2014
4	Carcinogenesis 01/2021 - 08/2019
4	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2019
4	Hyperthermia 10/2020 - 01/2014
4	Metaplasia 01/2020 - 01/2012
4	Lung Neoplasms (Lung Cancer) 07/2015 - 06/2014
3	Disease Progression 01/2022 - 04/2011
3	Fibrosis (Cirrhosis) 01/2022 - 10/2013
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2021 - 01/2021
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021 - 01/2019
3	Hyperlipidemias (Hyperlipidemia) 10/2020 - 01/2019
3	Hyperglycemia 10/2020 - 05/2012
3	Hypoxia (Hypoxemia) 01/2017 - 07/2013
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2010
15	Pharmaceutical PreparationsIBA 01/2022 - 03/2008
9	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2009
9	Messenger RNA (mRNA)IBA 10/2020 - 07/2007
8	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2020 - 01/2011
8	Therapeutic UsesIBA 01/2019 - 01/2011
7	CytokinesIBA 01/2022 - 01/2017
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2005
6	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2016
6	Peptides (Polypeptides)IBA 01/2022 - 01/2013
6	LipidsIBA 01/2022 - 01/2017
6	Singlet OxygenIBA 01/2021 - 01/2014
6	Long Noncoding RNAIBA 01/2021 - 07/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 09/2005
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2014
5	AndrogensIBA 01/2021 - 11/2009
5	SurvivinIBA 12/2014 - 09/2005
4	AntioxidantsIBA 01/2022 - 10/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2004
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2014
4	MicellesIBA 01/2021 - 01/2014
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2017
4	Apolipoproteins E (ApoE)IBA 01/2021 - 10/2019
4	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2017
4	Retinaldehyde (Retinal)IBA 01/2017 - 05/2012
4	Fluorescein (Funduscein)FDA LinkGeneric 08/2014 - 01/2011
4	Ophthalmic Solutions (Eye Drops)IBA 08/2014 - 01/2012
3	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2021
3	Biological ProductsIBA 01/2022 - 02/2014
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 01/2018
3	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2017
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 01/2014
3	Phosphotransferases (Kinase)IBA 01/2022 - 09/2013
3	CateninsIBA 01/2022 - 01/2019
3	NF-kappa B (NF-kB)IBA 01/2022 - 06/2009
3	CholesterolIBA 01/2021 - 01/2019
3	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2021 - 05/2017
3	Coloring Agents (Dyes)IBA 12/2020 - 05/2014
3	Photosensitizing Agents (Photosensitizers)IBA 10/2020 - 05/2014
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2020 - 05/2014
3	Tamoxifen FDA LinkGeneric 05/2019 - 04/2017
3	Oxygen (Dioxygen)IBA 01/2019 - 06/2016
3	Small Interfering RNA (siRNA)IBA 01/2018 - 10/2015
3	EctodysplasinsIBA 01/2018 - 01/2016
3	AntibodiesIBA 01/2017 - 06/2010
3	PlatinumIBA 07/2015 - 06/2014
2	Malondialdehyde (Propanedial)IBA 11/2022 - 10/2013
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2022 - 01/2022
2	EmulsionsIBA 01/2022 - 04/2011
2	CelluloseIBA 01/2022 - 11/2021
2	alpha-tomatineIBA 01/2022 - 01/2013
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2019
2	PolyaminesIBA 11/2021 - 01/2017
2	ApolipoproteinsIBA 01/2021 - 10/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 10/2013
2	LDL CholesterolIBA 01/2021 - 01/2019
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 10/2004
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2015
2	Insulin (Novolin)FDA Link 01/2021 - 09/2014
2	HDL LipoproteinsIBA 01/2021 - 01/2021
2	Hormones (Hormone)IBA 01/2021 - 01/2017
2	oxidized low density lipoproteinIBA 01/2021 - 01/2019

Therapy/Procedure

32	Therapeutics 01/2023 - 03/2008
8	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
6	Photothermal Therapy 01/2022 - 01/2014
4	Precision Medicine 06/2018 - 01/2014
3	Photochemotherapy (Photodynamic Therapy) 10/2020 - 05/2014
3	Topical Administration 09/2013 - 01/2011